Intrust Bank’s Sucampo Pharmaceuticals, Inc. SCMP Stock Holding History

Intrust Bank’s Portfolio SCMP Stock Details SCMP Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2018 Q1	–	Sell	-21,063	Closed	-$378K	–	388
2017 Q4	$378K	Buy	21,063 +1,023	+5%	+$12.6K	0.11%	254
2017 Q3	$236K	Buy	20,040 +4,445	+29%	+$49.9K	0.08%	331
2017 Q2	$164K	Buy	15,595 +2,026	+15%	+$20.7K	0.06%	375
2017 Q1	$149K	Buy	+13,569	New	+$157K	0.05%	365

Other funds holding SCMP

Glenmede Trust Philadelphia, Pennsylvania $20.4B AUM

IFP Advisors Tampa, Florida $5.54B AUM 27.43% 1-Year Est. Return

AIM

Advantage Investment Management Cedar Rapids, Iowa $128M AUM 0.94% 1-Year Est. Return

Intrust Bank's SCMP Position: Q1 2018 in Review

Intrust Bank sold out of Sucampo Pharmaceuticals, Inc. (SCMP) in Q1 2018, closing a stake of 21,063 shares — an estimated $378K sold.

Intrust Bank first reported a position in SCMP in Q1 2017 and held it in 4 quarters. The position peaked at $378K in Q4 2017. 3 funds tracked by Wall St. Rank hold SCMP as of Q1 2018.

Intrust Bank reported no remaining Sucampo Pharmaceuticals, Inc. position as of Q1 2018 after selling out during the quarter.
Intrust Bank sold 21,063 Sucampo Pharmaceuticals, Inc. shares in Q1 2018, an estimated $378K.
Intrust Bank first reported a position in Sucampo Pharmaceuticals, Inc. in Q1 2017 and held it in 4 quarters.
Intrust Bank's Sucampo Pharmaceuticals, Inc. position peaked at $378K in Q4 2017.
3 funds tracked by Wall St. Rank held Sucampo Pharmaceuticals, Inc. as of Q1 2018.

Based on Intrust Bank's 13F filing for Q1 2018, filed 3 May 2018.